This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Resource
  2. Source: Campus Sanofi
  3. 15 May 2025

Praluent® (alirocumab) Homecare Services

Author: Sanofi

Editorial Team

Praluent logo

Prescribing Information(GB)

Prescribing Information(NI)

Sanofi contracts a Homecare provider to provide homecare services free of charge

Homecare is run by experienced pharmacists who dispense Praluent® and arrange delivery to patients.

Adverse events table
  • In the NHS, homecare services support a range of benefits to key stakeholders
  • Homecare services are available to individual hospitals upon signature of a Service Level Agreement

Not all hospitals will utilise our Homecare service, please confirm your own situation

Contact Details for Homecare Providers

Sciensus

✉  generalenquiries@sciensus.com
☎  0333 103 9499

HealthNet

✉  enquiries@healthnethomecare.co.uk
☎  0800 083 3060

SEE MORE FROM SCIENCE

Praluent®

Find more information on Indication, Administration and Mechanism of Action and watch videos about Praluent®.

Patient Website

Find resources and support for your patients on Praluent®. Find useful links about how patients can manage their cholesterol.

Get in touch with the Dyslipidaemia Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2204602 (v9.0) Date of Preparation: May 2025